Thu.Feb 15, 2024

article thumbnail

Opinion: Independent doctors like me are becoming an endangered species

STAT

More than 100,000 doctors have  left private practice  and become employees of hospitals and other corporate entities since 2019. Today, nearly  three in four physicians  are employees of larger health care entities or other corporations — a record high. As an independent physician, I know exactly why so many are making that choice.

Hospitals 363
article thumbnail

Alnylam change to heart drug trial sparks doubts, sinking shares

BioPharma Dive

Analysts pressed Alnylam executives on the reasons for the changes to HELIOS-B, a Phase 3 study in ATTR amyloidosis with cardiomyopathy that is important to the company’s future.

126
126
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Juul’s internal playbook opens a rare window into influence in Washington

STAT

WASHINGTON — A new trove of internal emails and other documents from the e-cigarette maker Juul reveals the company’s extensive behind-the-scenes efforts to promote its interests in Washington — a rare insight into the otherwise opaque methods corporations use to influence the government. It’s well documented that Juul spent significant sums on registered lobbyists and political donations back in 2018 and 2019, when the head of the Food and Drug Administration declare

article thumbnail

‘Hey, AI: Is Zoloft effective for me?’ Tech’s foray into predictive prescribing

PharmaVoice

Researchers are unleashing the powers of AI for precision medicine, drug development and more.

article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

Lyme disease cases rise, but largely due to a change in data collection

STAT

A new report released Thursday by the Centers for Disease Control and Prevention appears to show that Lyme disease cases in the United States rose by 69% in 2022 over previous years. But in reality, the sharp increase is likely due to a new way of doing surveillance for the disease, not an explosion of cases. The change, an attempt to lift a crushing reporting burden off the shoulders of states where Lyme disease infections are common, went into effect in 2022.

359
359
article thumbnail

Guest Post: February is Marfan Awareness Month!

Putting Patients First Blog

Guest Post: February is Marfan Awareness Month! February 15, 2024 By: April Dawn Shinske, Chief Communications and Marketing Officer, The Marfan Foundation During Marfan Awareness Month 2024, members of the community living with Marfan syndrome — a genetic aortic and vascular condition that impacts connective tissue — have been sharing their diverse perspectives through short videos called #marfanrealreels.

More Trending

article thumbnail

HHS guidance on using online tracking technologies: How to make your analytics HIPAA-compliant

pharmaphorum

The HHS provides guidance on using online tracking technologies in a HIPAA-compliant manner. Learn how to ensure your analytics practices align with healthcare regulations and protect patient privacy.

HIPAA 119
article thumbnail

STAT+: FDA cracks down on websites that claim to sell chemicals in obesity drugs Wegovy, Zepbound

STAT

The Food and Drug Administration is cracking down on websites that claim to sell the underlying chemicals of popular diabetes and obesity drugs like Ozempic, Wegovy, and Zepbound, saying that the websites are selling unapproved and misbranded drug products. The regulator this week posted warning letters that it sent to two websites, Synthetix Inc. DBA Helix Chemical Supply and US Chem Labs.

Diabetes 343
article thumbnail

Textbook vs. Textbot: Investigating ChatGPT’s Role in Retrieval Practice 

Pulses

By: Morgan Lewis PharmD Candidate, Sara Stallworth PharmD, and Jeff Cain EdD, MS Introduction Nestled in library corners, pharmacy students sit hunched over desks, meticulously poring over their class notes, portraying a picture-perfect scene of “traditional studying.” Yet this romanticized version of studying may not be the best for learning. Students often use i nput-based study strategies , which can involve reading notes or rewatching video recordings, which have a goal of “cementing” the in

article thumbnail

STAT+: Hospital claims it was ‘drastically’ overcharged by pharma in a federal drug discount program

STAT

For several years , some of the world’s largest pharmaceutical companies that participate in a U.S. drug discount program overcharged the federal government and numerous hospitals by hundreds of millions of dollars, according to claims made in a recently unsealed lawsuit. The allegations, which were made by Adventist Health System, turn on the complicated, behind-the-scenes calculations used to provide medicines to what is known as the 340B program.

Hospitals 329
article thumbnail

Why Every Small Business Needs an HCM Solution: A Comprehensive Guide

Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.

article thumbnail

New chemotherapy treatment could benefit multiple cancer types

European Pharmaceutical Review

A clinical trial in malignant pleural mesothelioma (MPM) has demonstrated the first successful combination of chemotherapy with a drug targeting cancer’s metabolism developed for the asbestos-induced disease in two decades. The anti-cancer treatment combines the new drug ADI-PEG20 and traditional chemotherapy. The Phase III ATOMIC-meso trial was led by Queen Mary University of London in the UK and studied 249 patients with the disease.

article thumbnail

American Medical Association’s digital advisors table RPM coding reform proposal, again

STAT

You’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology is transforming the life sciences.  Sign up to get it  delivered in your inbox every Tuesday and Thursday. Remote patient monitoring coding reforms tabled again Earlier this month, an  American Medical Association -anointed panel was set to consider proposed changes that would have simplified and broadened applicability of billing codes governing wearables and other devices d

294
294
article thumbnail

Innsena backs CancerX’s digital drive to improve access

pharmaphorum

Healthtech specialist Innsena has committed funding and expertise to CancerX, launched last year to encourage the use of digital health technologies to overcome challenges in cancer care.

111
111
article thumbnail

Pharma’s contractors might finally be on the rebound

STAT

Want to stay on top of the science and politics driving biotech today?  Sign up  to get our biotech newsletter in your inbox. Hello, everyone. Damian here with a look at a complicatedly important ALS study, biotech’s latest volatility, and some green shoots for a downtrodden part of the industry.

article thumbnail

Best Practices to Streamline Compensation Management: A Foundation for Growth

Speaker: Joe Sharpe and James Carlson

Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.

article thumbnail

Psychedelic treatments for mental health: Is there substance behind the hype?

Pharmaceutical Technology

The success of recent trials treating mental health problems with psychedelic therapies has driven a rapid rise in investment in the area.

116
116
article thumbnail

STAT+: Gaming Amylyx stock reactions to the next ALS drug test, and a chat with CRISPR’s CEO about a new investor

STAT

This week, a preview of the TUDCA study in ALS and thoughts on how it might impact Amylyx Pharmaceuticals. Also, I chatted with CRISPR Therapeutics CEO Sam Kulkarni about its new investor. Read to the end for some burning questions, random thoughts. The next ALS data readout — overdue but important A European academic consortium is expected to announce results soon from a clinical trial investigating the use of a widely available nutritional supplement called tauroursodeoxycholic acid, or

277
277
article thumbnail

Exercise ‘may be better than drugs for depression’

pharmaphorum

Exercise matched psychotherapy and was more effective than medication as a treatment for #depression in a meta-analysis of randomised clinical trials

117
117
article thumbnail

Listen: Pharma goes to Washington, Alnylam’s future, & Gilead’s dealmaking

STAT

Has PhRMA lost its fangs? Are 11th-hour changes ominous for clinical trials? And what’s next in pain medicine? We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. The pharmaceutical industry, in court and in Congress, is working to water down legislation that will let Medicare negotiate certain drug prices.

article thumbnail

Enhance Healthcare Efficiency With Top Payroll & HCM Services

Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.

article thumbnail

Quarter of all Covid vaccines administered in community pharmacies

The Pharmacist

Almost two-thirds (62%) of Covid-19 vaccines were administered in community pharmacies in December 2023, according to the Company Chemists’ Association (CCA). The CCA’s analysis, based on data from NHS England and Freedom of Information requests, found that community pharmacy had administered more than 40 million Covid-19 vaccinations by the end of 2023 – a quarter […] The post Quarter of all Covid vaccines administered in community pharmacies appeared first on The Pharmacist.

article thumbnail

STAT+: Sick patients collapsed waiting for care at Mass. hospital with known safety violations

STAT

Struggling to breathe, the patient stepped out of the registration line in the hospital’s overwhelmed emergency department to find help. Her chest hurt, she told the triage nurse on duty that evening at Brockton’s  Good Samaritan Medical Center. The nurse, backed up with more than a dozen waiting patients, thought it was anxiety and told her to get back in line.

Hospitals 238
article thumbnail

Nelson Labs facility expansion to benefit parenteral and ophthalmic drug product manufacturers

European Pharmaceutical Review

The investment… includes state-of-the-art instrumentation to provide full CMC support to serve the growth of PODP [manufacturers]” Nelson Labs, a global leader in microbiological and analytical chemistry testing and advisory services for the medical device and pharmaceutical industries has announced its Itasca, Illinois laboratory in the US as a new Pharmaceutical Center of Excellence to serve the unique needs of parenteral and ophthalmic drug product (PODP) manufacturers.

98
article thumbnail

STAT+: Pharmalittle: We’re reading about a FTC probe into GPOs, a frostbite drug, and more

STAT

Top of the morning to you, and a fine one it is. Clear blue skies are enveloping the Pharmalot campus this morning, where the official mascots continue to enjoy the tundra-like grounds and we are brewing yet another cup of stimulation. Our choice today, for those who track this sort of thing, is bananas Foster. As always, you are welcome to join us.

article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

Aurlumyn Gets First FDA Approval for a Severe Frostbite Medication

Pharmaceutical Commerce

Patients with severe frostbite who were administered Aurlumyn monotherapy experienced a significantly reduced risk of the need for amputation.

109
109
article thumbnail

Drug Excipient Business Development Reports now Available on Amazon

Drug Patent Watch

Elevate your excipient business strategies with the comprehensive Drug Excipient Business Development Reports from DrugPatentWatch. Designed for excipient manufacturers seeking lucrative opportunities in the pharmaceutical industry, these reports offer invaluable… The post Drug Excipient Business Development Reports now Available on Amazon appeared first on DrugPatentWatch - Make Better Decisions.

99
article thumbnail

Prime Medicine joins the biotech IPO queue, seeking $140m

pharmaphorum

Gene-editing biotech Prime Medicine has priced an initial public offering, hoping to raise $140 million to advance its pipeline of one-shot therapies for severe genetic disorders. The Cambridge, Massachusetts-based company is offering 19.2 million shares at $6.25 each and expects to start trading on the Nasdaq on 20th February under the PRME symbol.

103
103
article thumbnail

The roadblocks faced by Biogen are many, but execs point to an R&D-focused turnaround

PharmaVoice

A disappointing few years for Biogen have led leadership to use new drug launches as fuel for an about-face.

100
100
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

Closed Loop Medicine shares results of proprietary technology for hypertension

Pharma Times

CLM-HT01 improved blood pressure and minimised adverse reactions in patients

article thumbnail

Biotechs ride obesity drug wave with novel approaches that go beyond GLP-1RAs

Pharmaceutical Technology

As the market is progressively becoming saturated by GLP-1 receptor agonists, companies are investigating alternative mechanisms of action.

105
105
article thumbnail

Stroke brain-bleed deaths predicted to increase by 40% in the UK

Pharma Times

In Europe, stroke-related brain-bleed deaths are expected to increase by 8.

136
136
article thumbnail

Advarra's breakthrough in science technology with single sign-on for sites

Outsourcing Pharma

At most major conferences, there is usually a topic or buzzword that everyone talks about - and at this yearâs SCOPE held in Orlando this week, it was no different.

100
100
article thumbnail

FTC targets middlemen in generic drug shortages probe

pharmaphorum

The FTC is investigating wholesalers and other middlemen in the pharma supply chain to assess their possible role in worsening shortages of generic medicines